Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases

Jie Huang, Wenqiang Zhu, Qiangzhi Duan, Chaomang Zhu, Xueling Shi, Hongyu Zhao, Peng Cai, Duojie Li · 2023

Read Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases by Jie Huang, Wenqiang Zhu, Qiangzhi Duan, Chaomang Zhu, Xueling Shi, Hongyu Zhao, Peng Cai, Duojie Li (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10661917.txt.

Description

Jie Huang and a team of co-authors compare pairing radiation with a targeted drug for breast cancer spread to the brain, in a paper dated twenty twenty-three. The cancer type carries the HER2 marker, and all patients took pyrotinib. Sixty-six also got radiation, while twenty-six took the drug alone.

The paired group answered treatment more often, at about fifty-five percent versus thirty-five. Their cancer also stayed quiet in the brain longer, twelve months against eight. A stronger split-dose radiation plan beat the standard plan on both control and survival. No grave side effects appeared in either group.

Catalog record

CREATORJie Huang, Wenqiang Zhu, Qiangzhi Duan, Chaomang Zhu, Xueling Shi, Hongyu Zhao, Peng Cai, Duojie Li
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10661917

Browse the full library · About the Tower of Babel